Founded in 1974, EMBL is Europe’s flagship laboratory for the life sciences – an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton.
Antibodies and bicyclic peptides - paradigm shifts in the world of pharmaceutical drugs
Sir Dr. Gregory Winter, MRC Laboratory of Molecular Biology, Trinity College Cambridge, Bicycle Therapeutics
17:15 - Large Operon
mTOR signaling in growth and metabolism
Michael N. Hall, Biozentrum, University of Basel
11:00 - Large Operon
To be announced
Stephan Preibisch, Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine (MDC)
11:00 - Small Operon